Doha, Qatar: Sidra Medicine will host RAPID 2026 from September 25–27, bringing together international experts, clinicians and researchers to discuss advances in primary immune dysregulation disorders.

Under the theme “Frontiers in Diagnostics for Primary Immunodysregulation Disorders,” the conference will explore new approaches to diagnosis, management and research in primary and genetic immune disorders.

The three-day event will feature scientific sessions, multidisciplinary discussions and a master class on inborn errors of immunity. It will also highlight developments in genomics, precision diagnostics and translational research. Organised in collaboration with the Isil Berat Barlan Academy and the Universal Scientific Education and Research Network, the conference aims to strengthen regional and international collaboration and support improved patient care.

Click here to join our WhatsApp channel here

Dr. Bernice Lo, Principal Investigator from the Laboratory of Immunoregulation and Conference Co-Chair, said: “RAPID 2026 reflects Sidra Medicine’s commitment to advancing research and improving outcomes for patients with rare and complex immune disorders. We have a strong line-up of international and regional experts, including Prof. Talal Chatila, a leading expert in translational immunology presenting as a keynote speaker this year.  By bringing together global experts from multiple disciplines, we aim to accelerate knowledge exchange, strengthen international collaboration, and promote earlier diagnosis and more personalized approaches to care.”

Dr. Mohammed Yousuf Karim, Division Chief of Hematology and Sidra Conference Co-Chair, added: “The field of immune dysregulation is evolving rapidly, driven by advances in genomics, diagnostics, and translational research. RAPID 2026 will be an important platform for clinicians and scientists to share emerging evidence, discuss complex clinical cases, and shape future standards of care for patients across the region and beyond.”

RAPID 2026 is open to healthcare professionals, researchers and scientists working in immunology and related fields, with registration and abstract submissions currently available.

Also read: Healthcare Benefits Expanded for Drivers Through New Egypt Partnership